Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI
Journal of Nuclear Medicine · 30.10.2024 · jnumed.124.268443
DOI: 10.2967/jnumed.124.268443 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 30.10.2024. Verfasst von Ida Sonni und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Sciences, UCLA, Los Angeles, California; isonni@mednet.ucla.edu. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Multiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT are complementary imaging modalities used in the presurgical evaluation of patients with prostate cancer (PCa). The purpose of this study was to characterize clinically significant PCa (csPCa) detected and not detected by PSMA PET/CT and mpMRI, focusing on tumors detected solely by PSMA PET/CT and overlooked by mpMRI.
Methods
We conducted a single-center, retrospective analysis of patients who underwent both PSMA PET/CT and mpMRI within 3 mo of each other and before radical prostatectomy. Two nuclear medicine physicians and 2 radiologists, in a masked manner, independently contoured PCa lesions on PSMA PET/CT and mpMRI, respectively. A consensus read was done with a third reader for each modality, and a majority rule was applied (2:1). After centralized imaging, a pathologic review was done by a genitourinary pathologist. We assessed agreement between imaging modalities and correlation with pathology. Logistic regression models explored associations between clinicopathologic variables and tumor detection on imaging.
Results
In total, 132 csPCa tumors from 100 patients were identified on surgical pathology. PSMA PET/CT showed higher lesion-level (87% vs. 80%) and patient-level (98% vs. 94%) sensitivity than mpMRI. Tumors detected on both imaging modalities were larger and had higher grade groups than those not detected by one or both imaging modalities. On multivariable analysis, csPCa tumors undetected by mpMRI but detected by PSMA PET/CT were smaller than those detected by both modalities. Most tumors showing aggressive pathologic features, such as the large cribriform pattern (94.7%) and the intraductal carcinoma (96%), were correctly detected by both imaging modalities. Limitations included selection bias in a surgical cohort.
Conclusion
PSMA PET/CT tends to detect smaller csPCa not detected by mpMRI. Larger tumors on pathology with higher grade groups are more likely to be correctly detected by both imaging modalities. These findings provide insights for refining presurgical evaluation strategies in PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiological Sciences, UCLA, Los Angeles, California; isonni@mednet.ucla.edu.
- Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy.
- Department of Urology, UCLA, Los Angeles, California.
- Institute for Precision Health, UCLA, Los Angeles, California.
- Department of Radiological Sciences, UCLA, Los Angeles, California.
- Department of Medicine Statistics Core, UCLA, Los Angeles, California.
Zitieren
APA
Sonni, I., Weiner, A. B., Doddipalli, S., Deol, M., Ban, D., Kim, H. O., Grogan, T., Ahuja, P., Barroso, N., Zong, Y., Soin, P., Sisk, A., Czernin, J., Hsu, W., Calais, J., Reiter, R. E., & Raman, S. S. (2024). Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI. Journal of Nuclear Medicine, jnumed.124.268443. https://doi.org/10.2967/jnumed.124.268443
Vancouver
Sonni I, Weiner AB, Doddipalli S, Deol M, Ban D, Kim HO, et al. Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI. Journal of Nuclear Medicine. 2024:jnumed.124.268443. doi:10.2967/jnumed.124.268443
BibTeX
@article{Sonni2024,
author = {Sonni, Ida and Weiner, Adam B and Doddipalli, Sahith and Deol, Madhvi and Ban, David and Kim, Hye Ok and Grogan, Tristan and Ahuja, Preeti and Barroso, Nashla and Zong, Yang and Soin, Priti and Sisk, Anthony and Czernin, Johannes and Hsu, William and Calais, Jeremie and Reiter, Robert E and Raman, Steven S},
title = {Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI},
journal = {Journal of Nuclear Medicine},
year = {2024},
pages = {jnumed.124.268443},
doi = {10.2967/jnumed.124.268443}
}
EUVIMED